Trial Profile
A trial of abatacept to determine its effect on subclinical atherosclerosis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Feb 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Atherosclerosis
- Focus Therapeutic Use
- 01 Feb 2016 New trial record